Novoste (novt) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novoste (novt)

NOVT 130.94

+1.7%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Zantac who wrote (64)	7/4/1999 10:36:00 AM
From: Oak Tree	Read Replies (2) of 100

I'm still in a short position. As you know I got in at 25.375. I'm trying to get 20. I still think we will see 15 again soon. The in-stent trial is completed and the denovo lesion trial is going a bit rocky (as evidenced by the delay in completion and the increase in the size of the study. Technically speaking, in-stent radiation is not a good place for electron treatments to excell (electrons won't penetrate the stent). The data won't be reported for a few months on the stent trial and the no-stent trial is going rocky as discussed above. Since the company is not making any money, the average investor is not likely to cut them much slack. Anything less than stellar performance is likely to hurt the stock. If J&J is planing to buy the company, and does their due diligence, they will wait till the results of the study are published to get the company cheap. My guess is similar to yours however. I think that if I cover my short near here (i'm looking for 20), I might be able to sell it again when if the market momentum takes it back over 23 or 24. Paul

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next